Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
A study from Krembil Research Institute at UHN has uncovered a set of proteins that could help doctors diagnose two different forms of arthritis more quickly.
Psoriatic arthritis is an inflammatory condition that affects the joints, causing pain and stiffness. Clinicians who have limited experience with the disease may find it difficult to diagnose psoriatic arthritis, which is often confused with another type of arthritis known as osteoarthritis.
In the study, Krembil researchers sought to identify new markers that could distinguish between these two forms of arthritis. To this end, they compared the levels of different proteins in blood samples from individuals with psoriatic arthritis or osteoarthritis, as well as healthy individuals.
They identified four proteins – cartilage oligomeric matrix protein, resistin, monocyte chemoattractant protein and nerve growth factor – that were significantly higher in blood samples from patients with psoriatic arthritis. By measuring the levels of these proteins, researchers were consistently able to differentiate patients with psoriatic arthritis from those with osteoarthritis.
"Early diagnosis and treatment of psoriatic arthritis is crucial as it can prevent further joint damage and improve quality of life for patients," says Dr. Dafna Gladman, senior author of the study.
"Although further testing is needed, we believe that these markers have the potential to improve the diagnosis and care of patients with osteoarthritis and psoriatic arthritis."
This work was supported by the Krembil Foundation and the Toronto General & Western Hospital Foundation.